Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission.

Saved in:
Bibliographic Details
Title: Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission.
Authors: Wilson JG; Department of Emergency Medicine, Stanford University School of Medicine, Stanford, CA., Grandits GA; Division of Biostatistics and Health Data Science, University of Minnesota School of Public Health, Minneapolis, MN., Grund B; School of Statistics, University of Minnesota, Minneapolis, MN., Mistry SS; Division of Biostatistics and Health Data Science, University of Minnesota School of Public Health, Minneapolis, MN., Leroux C; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA., Ringor A; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA., Aggarwal NR; Department of Pulmonary Sciences and Critical Care, University of Colorado School of Medicine, Aurora, CO., Murray DD; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Barkauskas CE; Department of Medicine, Division of Pulmonary and Critical Medicine, Duke Medicine, Durham, NC., Brown SM; Department of Critical Care, Intermountain Medical Center, Salt Lake City, UT.; Department of Medicine, University of Utah, Salt Lake City, UT., Higgs E; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD., Shaw-Saliba K; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD., Rupert A; Frederick National Laboratory, Frederick, MD., Kan VL; VA Medical Center and George Washington University School of Medicine and Health Sciences, Washington, DC., Beitler JR; Aspire Trials Program, Division of Pulmonary, Critical Care and Sleep Medicine, NYU Grossman School of Medicine, New York, NY., Awan O; VA Medical Center and George Washington University School of Medicine and Health Sciences, Washington, DC., Sturgill JL; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY., Dawood H; Department of Medicine, Greys Hospital, Pietermaritzburg, South Africa., Kalil AC; Division of Infectious Diseases, University of Nebraska College of Medicine, Omaha, NE., Kalomenidis I; Department of Critical Care and Pulmonary Medicine, Medical School, National and Kapodistrian University of Athens, Evangelismos General Hospital, Athens, Greece., Duggal A; Department of Critical Care, Integrated Hospital Care Institute, Cleveland Clinic, Cleveland, OH., Sasson SC; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Ho MQ; Department of Internal Medicine, College of Medicine, University of Central Florida and Department of Internal Medicine, Section Infectious Disease, Orlando VA Healthcare System, Orlando, FL., Nguyen HH; VA Northern California Health Care System University of California, Davis Health, Sacramento, CA., Lundgren JD; CHIP (Centre of Excellence for Health, Immunity and Infections), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Ginde AA; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO., Self WH; Vanderbilt Institute for Clinical and Translational Research and Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN., Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD., Matthay MA; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA., Rogers AJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Corporate Authors: Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE) Network and Therapeutics for Inpatients with COVID-19 (TICO) Trial Study Group
Source: Critical care medicine [Crit Care Med] 2026 May 25. Date of Electronic Publication: 2026 May 25.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0355501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0293 (Electronic) Linking ISSN: 00903493 NLM ISO Abbreviation: Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0293
DOI:10.1097/CCM.0000000000007178